✦ LIBER ✦

O-56 Symptom and quality of life advantages for pemetrexed + cisplatin versus cisplatin in treatment of malignant pleural mesothelioma

✍ Scribed by Boyer, M.J.; Jassem, J.; Liepa, A.M.; Symanowski, J.T.; Kaukel, E.; Denham, C.A.; Paz-Ares, L.; Gralla, R.J.; Hnllen, P.J.; Nguyen, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN2 VALUE-FOR-MONEY OF PEMETREXED PLUS C

✍ P Davey; A Cordony; N Rajan; B Arora; N Pavlakis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Comparison of cisplatin plus pemetrexed

✍ Shukuya, Takehito; Takahashi, Toshiaki; Imai, Hisao; Tokito, Takaaki; Ono, Akira 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 398 KB

Cost-Effectiveness of Pemetrexed Plus Ci

✍ Anna Cordony; Corinne Le Reun; Antje Smala; James T. Symanowski; Jessamy Watkins 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

P-431 Updated multiple regression analys

✍ Symanowski, J.; Rusthoven, J.; Vogelzang, N. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Pleural space perfusion with cisplatin i

✍ Giovanni B. Ratto; Dario Civalleri; Mauro Esposito; Elisabetta Spessa; Antonella 📂 Article 📅 1999 🏛 CTSNet 🌐 English ⚖ 69 KB

P-401 Evaluating improvement in patient-

✍ Gralla, R.; Symanowski, J.; Boyer, M.; Paoletti, P.; Rusthoven, J.; Manegold, C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 298 KB